Skip to main content
Premium Trial:

Request an Annual Quote

Metabolon Nets $6M in New VC Funding

NEW YORK (GenomeWeb News) – Metabolon has reeled in $6 million in new Series C financing from new investors Syngenta Ventures and Fletcher Spaght Ventures, and from previous investors, bringing the total funding for the round to $12.3 million, the company said today.

The Research triangle Park, NC-based metabolomic diagnostics company also said that it has agreed to expand an earlier research collaboration with Syngenta, and that Syngenta Ventures VP Carol Marina and Fletcher Spaght VP Guy Fish have joined its board of directors.

The investment was the first for Syngenta Ventures, the new VC subsidiary of plant genomics firm Syngenta.

The two new investors joined previous investors Seven Rosen Funds, Aurora Funds, Harris and Harris Group, Fulcrum Financial Partners and Alexandria Equities in the round.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.